Hepion Pharmaceuticals raises $500,000 via 8% secured convertible note
Hepion Pharmaceuticals entered into a financing with Gravitas Capital, issuing a $500,000 secured convertible note and a warrant for 12,500,000 shares. The note carries 8% PIK interest and matures Sep 3, 2027.
Hepion Pharmaceuticals entered into a financing with Gravitas Capital, issuing a $500,000 secured convertible note and a warrant for 12,500,000 shares. 04 per share after stockholders approve an increase in authorize…